Manufacturing Digital: Search Results

Lam Research Corporation Announces Financial Results for the Quarter Ended December 25, 2011

Lam Research Corporation Contact:
Shanye Hudson
Director, Investor Relations
Phone: 510-572-4589
e-mail: shanye.hudson@lamresearch.com

Zephyr Photonics Adds Networking and Fiber Optics Experts to Lead Engineering and Component Operations

Media Contact:
Kevin Wilson
Email Contact
513-898-1008

Swiss Department of Defence Becomes Centaur Launch Customer

Contact:
Patricia Woodside
Director, Public Relations
(703) 396-6304
Email Contact

Bell Aquaculture Teams with Indiana Soybean Alliance, Virginia Cobia Farms and The Conservation Fund's Freshwater Institute, Showcasing the "Future of Fish"

Bell Aquaculture, a pioneer in sustainable fish farming operations, joined forces with Indiana Soybean Alliance, Virginia Cobia Farms and The Conservation Fund's Freshwater Institute to present the "Future of Fish," January 11, 2012, at Bell's facilities in Albany and Redkey, IN.

GM unveils interactive touchscreen car window

General Motors and students at Israel's Bezalel Academy of Art and Design have unveiled 'Windows of Opportunity', a new form of interactive in-car entertainment

Samsung plans record $41.4 billion investment in 2012

Samsung Group is planning a massive expansion programme by investing a record $41.4 billion in 2012

Huaxing Machinery Corp. Reports the Successful Development and Sale of New Product and Appointment of CEO

Huaxing Machinery Corp.
Ming (Barry) Sheng
Investor Relations Manager
778-882-9677
mingbarrysheng@gmail.com

Highpower to Attend 2012 CES in Las Vegas

Media and Investor Inquiries:
Vickie Hawes
Corporate Communications Manager
+1 (650) 903-2210
Email Contact

Financial Profiles, Inc.
Tricia Ross
+1 (916) 939-7285
Email Contact

RE2, Inc. Wins Phase II SBIR to Develop a Highly Dexterous Manipulation System

RE2, Inc. Media Contact:
RE2 Public Relations
Email Contact
412.681.6382

Aurora Delivers First Ship Set of Composite Structures for the BAMS UAS Program

Contact:
Patricia Woodside
Director, Public Relations
(703) 396-6304
Email Contact

D-Link Successfully Passes Second Round of IPv6 Interoperability Testing

FOUNTAIN VALLEY, Calif., Dec. 22, 2011 /PRNewswire/ -- D-Link successfully completed a new round of IPv6 interoperability testing at the University of New Hampshire InterOperability Laboratory's (UNH-IOL) third IPv6 Customer Edge (CE) Router Interoperability Test Event held Nov. 7-11, 2011....

Isle of Man TT Zero

Showcasing motorcycle enterprise, innovation and clean technology

FIA Veteran Gabriel Cadringher Named GRAND-AM Chief Technical Consultant

DAYTONA BEACH, Fla., Dec. 14, 2011 /PRNewswire/ -- Gabriel Cadringher will take 30 years of expertise working at international motorsports' highest levels to GRAND-AM Road Racing in 2012 in the role of chief technical consultant, GRAND-AM President Tom Bledsoe announced...

Raising the Bar: Full Cancellation Doubles Data Rates, Reach and Revenue Potential From Next-Generation Service Provider Networks

Gwen Dille
Headfirst Communications
510-406-2006
Email Contact

PCI Synthesis Completes R&D Expansion

Contact:
Margaret Bonilla
Birnbach Communications
603-548-0693
Email Contact

Battelle CEO Jeff Wadsworth to Discuss Innovation at Potomac Institute Event

For more information contact

Katy Delaney
(614) 424-7208
Email Contact

T.R. Massey
(614) 424-5544
Email Contact

Arteriocyte Takes the Lead in Promoting Building Future Pipeline of Women in STEM Career Fields

CLEVELAND, Dec. 13, 2011 /PRNewswire/ -- Don Brown, CEO of Arteriocyte Cellular Therapies Medical Systems (Arteriocyte) and Terri Sandu, Executive Director of Hard Hatted Women (HHW), are combining efforts to raise awareness of opportunities for women in Science, Technology, Engineering and...

Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound

PRINCETON, NJ and NANJING, China, Dec. 13, 2011 /PRNewswire-Asia/ -- Bristol-Myers Squibb Company (NYSE: BMY) and Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company in China, today announced that the companies have expanded the strategic partnership formed last year...

Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121 in Combination with Cetuximab and Irinotecan in Patients with Advanced Cancers

CAMBRIDGE, Mass., Dec. 13, 2011 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a Phase 1 clinical study combining MM-121, a fully human monoclonal antibody that targets ErbB3, with cetuximab (Erbitux®) and irinotecan...

SANYO HIT(R) Solar Modules to Become "Panasonic HIT(R)"

Press Contact:
Hunter LaVigne Communications Inc.
Mark LaVigne, APR, FCPRS
905-841-2017 (office)
416-884-2018 (cell)
mark.lavigne@sympatico.ca

Search Results “research and development”